News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Dybul Mark
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/15/2022 |
4
| Dybul Mark (CEO) has filed a Form 4 on Enochian Biosciences Inc|
Txns:
| Granted 350,000 options to buy
@ $2.54, valued at
$889k
|
|
| 07/22/2021 |
4
| Dybul Mark (CEO) has filed a Form 4 on Enochian Biosciences Inc|
Txns:
| Granted 2,000,000 options to buy
@ $4.57, valued at
$9.1M
|
|
| 12/16/2020 |
4
| Dybul Mark (Executive Vice Chair) has filed a Form 4 on Enochian Biosciences Inc|
Txns:
| Acquired 180 shares
@ $0 |
|
| 06/19/2020 |
4
| Dybul Mark (Executive Vice Chair) has filed a Form 4 on Enochian Biosciences Inc|
Txns:
| Granted 450,000 options to buy
@ $8, valued at
$3.6M
|
|
| 08/01/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/03/2019 |
4
| Dybul Mark (Executive Vice Chair) has filed a Form 4 on Enochian Biosciences Inc|
Txns:
| Acquired 3,732 shares
@ $0 |
|
| 12/07/2018 |
4
| Dybul Mark (Director) has filed a Form 4 on Enochian Biosciences Inc|
Txns:
| Granted 300,000 options to buy
@ $6.5, valued at
$2M
|
|
| 09/27/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/10/2018 |
3
| Dybul Mark (Director) has filed a Form 3 on Enochian Biosciences Inc |
|
|